In the North American medical devices industry, there were 65 M&A deals announced in Q2 2023, worth a total value of $4.9bn, according to GlobalData’s Deals Database. The $1.8bn acquisition of spectrum plastics group by dupont de nemours was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity in North America decreased by 16% in Q2 2023 compared with the previous quarter’s total of $5.8bn and rose by 82% as compared to Q2 2022. Related deal volume decreased by 12% in Q2 2023 versus the previous quarter and was 24% lower than in Q2 2022.
The top-ranked financial advisors supporting these M&A deals in North America in Q2 2023 were UBS Group; Bank of America; Jefferies Financial Group with 5, 3, 3 deals respectively.
The top-ranked legal advisors supporting these M&A deals in North America Q2 2023 were Skadden, Arps, Slate, Meagher & Flom LLP & Affiliates; Goodwin Procter; Baker & McKenzie with 5, 4, 3 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
